A growing ageing population, favourable tax incentives and high demand for medicines confirm Central America’s ability to continue offering revenue-generating opportunities to foreign drugmakers. However, the region’s growing preference for traditional medicines could interfere with productive sales in coming years.

Headline Expenditure Projections

· Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +5.6%. Our forecast has been revised upwards since Q115 due to historical data.

· Healthcare: USD16.8bn in 2014 to USD17.8bn in 2015; +5.7 %. Our forecast has been revised upwards since Q115 due to revised historical data.